The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 19, 2025 for Tenshi Pharmaceuticals Pvt Ltd

Promoter holding below 50%Ownership Changes View source PDF Explain this filing

ONESOURCE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.8%Reaction day

₹1680.00

prior close

₹1697.00

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+1.3%+0.5% vs market

Pharmaceuticals peers, median of 153sector+0.6%+1.1% vs sector

On the reaction day the stock moved 0.5 pts more than Nifty Smallcap 250 and 1.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

+0.2

15m

+0.2

30m

+0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.8+1.3+0.5+0.6+1.1

Next day

+1.1+2.3-1.2+1.3-0.2

+2.1+2.7-0.6+1.4+0.7

+1.6+2.8-1.2+1.4+0.2

+4.1+2.6+1.5+0.7+3.4

+4.6+2.1+2.6-0.0+4.7

+7.7+3.0+4.7+0.7+7.0

15d

+2.4-0.6+2.9-1.1+3.5

+1.8-1.0+2.9-2.1+4.0

-22.0-1.3-20.8-3.9-18.1

-14.0-8.9-5.2-10.1-4.0

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 153Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Onesource Specialty Pharma's promoter Tenshi Pharmaceuticals Pvt Ltd has created a pledge on 20,00,000 equity shares (1.75% of total share capital) on December 16, 2025. The pledge was taken for a loan against shares to meet certain business and operational needs, with Catalyst Trusteeship Limited named as the entity holding the encumbered shares. After this pledge, Tenshi's encumbered shares rise to 86,51,274 (7.55% of share capital), and the total promoter group encumbrance stands at 94,37,176 shares (8.24% of share capital). The overall promoter group holding in Onesource Specialty Pharma is 3,42,96,199 shares, representing 17.91% of the company's share capital.

Likely market impact

This is a routine disclosure of a new promoter share pledge against a loan, not a change in ownership. It signals that the promoter is leveraging its stake for funding, which adds a layer of risk if the loan is not repaid; however, the promoter group's overall stake of 17.91% remains well below the 50% threshold.